UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$745M |
| 2 |
Spotify
SPOT
|
+$727M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$689M |
| 4 |
Meta Platforms (Facebook)
META
|
+$680M |
| 5 |
NXP Semiconductors
NXPI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$1.33B |
| 2 |
Union Pacific
UNP
|
+$1.2B |
| 3 |
Equinix
EQIX
|
+$929M |
| 4 |
Broadcom
AVGO
|
+$805M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$685M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.43% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.57% |
| 4 | Consumer Discretionary | 10.41% |
| 5 | Communication Services | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Morgan Stanley
MS
$294B
| $1.63B | 0.34% |
9,171,655
+83,472
| +0.9% | +$13.9M |
2013 Q2
50 quarters
|
|
52
Gilead Sciences
GILD
$182B
| $1.6B | 0.34% |
13,000,814
+12,299
| +0.1% | +$1.49M |
2013 Q2
50 quarters
|
|
53
Amgen
AMGN
$220B
| $1.51B | 0.32% |
4,604,019
+54,721
| +1% | +$17.4M |
2023 Q1
11 quarters
|
|
54
PepsiCo
PEP
$175B
| $1.45B | 0.31% |
10,130,364
-2,415,642
| -19% | -$355M |
2013 Q2
50 quarters
|
|
55
S&P Global
SPGI
$119B
| $1.45B | 0.31% |
2,778,491
+5,654
| +0.2% | +$2.8M |
2016 Q2
38 quarters
|
|
56
Verizon
VZ
$193B
| $1.45B | 0.31% |
35,627,861
-1,379,663
| -4% | -$56M |
2013 Q2
50 quarters
|
|
57
Accenture
ACN
$128B
| $1.45B | 0.31% |
5,393,818
+63,760
| +1% | +$16.2M |
2013 Q2
50 quarters
|
|
58
Thermo Fisher Scientific
TMO
$241B
| $1.41B | 0.3% |
2,428,731
+13,728
| +0.6% | +$7.76M |
2013 Q2
50 quarters
|
|
59
Abbott
ABT
$170B
| $1.39B | 0.29% |
11,058,894
+602,415
| +6% | +$76.7M |
2013 Q2
50 quarters
|
|
60
Vertex Pharmaceuticals
VRTX
$128B
| $1.36B | 0.29% |
3,000,778
+113,661
| +4% | +$49M |
2013 Q2
50 quarters
|
|
61
TJX Companies
TJX
$153B
| $1.33B | 0.28% |
8,688,601
+447,162
| +5% | +$66.1M |
2013 Q2
50 quarters
|
|
62
Citigroup
C
$215B
| $1.33B | 0.28% |
11,403,443
-638,828
| -5% | -$66.3M |
2013 Q2
50 quarters
|
|
63
Booking.com
BKNG
$120B
| $1.32B | 0.28% |
6,153,675
-640,550
| -9% | -$132M |
2013 Q2
50 quarters
|
|
64
Texas Instruments
TXN
$263B
| $1.31B | 0.28% |
7,539,966
-708,719
| -9% | -$121M |
2013 Q2
50 quarters
|
|
65
Blackrock
BLK
$165B
| $1.3B | 0.27% |
1,214,626
+108,746
| +10% | +$119M |
2013 Q2
50 quarters
|
|
66
Progressive
PGR
$127B
| $1.29B | 0.27% |
5,682,248
-174,651
| -3% | -$39.4M |
2013 Q2
50 quarters
|
|
67
Analog Devices
ADI
$197B
| $1.28B | 0.27% |
4,711,769
-33,262
| -0.7% | -$8.36M |
2013 Q2
50 quarters
|
|
68
AT&T
T
$170B
| $1.25B | 0.26% |
50,375,637
+482,321
| +1% | +$12.2M |
2013 Q2
50 quarters
|
|
69
Arista Networks
ANET
$266B
| $1.25B | 0.26% |
9,528,887
+287,385
| +3% | +$39.6M |
2015 Q2
42 quarters
|
|
70
RTX Corp
RTX
$248B
| $1.23B | 0.26% |
6,717,600
+931,189
| +16% | +$162M |
2013 Q2
50 quarters
|
|
71
Lowe's Companies
LOW
$106B
| $1.21B | 0.26% |
5,029,665
+411,154
| +9% | +$98.7M |
2013 Q2
50 quarters
|
|
72
KLA
KLAC
$257B
| $1.18B | 0.25% |
9,681,170
-153,870
| -2% | -$18M |
2013 Q2
50 quarters
|
|
73
Cadence Design Systems
CDNS
$96.1B
| $1.16B | 0.25% |
3,708,027
-76,291
| -2% | -$24.9M |
2013 Q2
50 quarters
|
|
74
Bristol-Myers Squibb
BMY
$122B
| $1.16B | 0.24% |
21,437,586
-351,360
| -2% | -$16.9M |
2013 Q2
50 quarters
|
|
75
Danaher
DHR
$153B
| $1.15B | 0.24% |
5,011,650
-23,253
| -0.5% | -$5.11M |
2013 Q2
50 quarters
|
|
Similar funds
UBS AM's Q4 2025 Portfolio in Review
As of Q4 2025, UBS AM held 3,345 positions worth $473B, up 2.7% from $461B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
UBS AM's Q4 2025 filing shows 1,074 new, 1,062 increased, 1,120 reduced and 60 closed positions. Its largest new stake was Chubb: 2,548,307 shares worth $795M. The largest sale was Prologis, an estimated $1.33B.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q4 2025 buy was Chubb: 2,548,307 shares worth $795M.
- UBS AM added most to Spotify in Q4 2025, an estimated $727M increase.
- UBS AM's biggest Q4 2025 reduction was Prologis, cutting an estimated $1.33B.
- UBS AM fully exited Kellanova in Q4 2025, selling an estimated $211M.
- UBS AM's ten largest holdings make up 36% of its $473B portfolio in Q4 2025.
- UBS AM opened 1,074 new positions and closed 60 in Q4 2025.
- UBS AM's portfolio value rose 2.7% quarter-over-quarter to $473B.
Based on UBS AM's 13F filing for Q4 2025, filed 13 Feb 2026.